IDHC: 37% revenue growth and margin gains in H1 2026, with expansion prioritized over dividends
H1 2026 saw 37% revenue growth, margin expansion, and strong profitability, led by Egypt and rapid progress in Saudi Arabia. No interim dividend will be paid as cash is preserved for expansion. Guidance for FY 2026 includes EGP 11bn revenue and 37% EBITDA margin.Based on Integrated Diagnostics Hold…
H1 2026 saw 37% revenue growth, margin expansion, and strong profitability, led by Egypt and rapid progress in Saudi Arabia. No interim dividend will be paid as cash is preserved for expansion. Based on Integrated Diagnostics Hold…